The creation of retatrutide, a novel dual stimulant targeting both GLP-1 and GIP receptors, represents a complex complicated synthetic process. Preliminary routes focused on amino acid chain fragment coupling, https://rafaelfrwt045227.diowebhost.com/95882766/synthesis-and-research-implementations-of-retatrutide